Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,805 | 175,910 | 192,585 | 214,331 | 226,748 |
| TOTAL | $158,886 | $182,648 | $196,367 | $215,192 | $228,564 |
| Non-Current Assets | |||||
| PPE Net | 1,743 | 1,121 | 804 | 466 | 483 |
| Other Non-Current Assets | 874 | 1,003 | 739 | 838 | 935 |
| TOTAL | $2,617 | $2,124 | $1,543 | $1,304 | $1,418 |
| Total Assets | $161,503 | $184,772 | $197,910 | $216,496 | $229,982 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,332 | 7,093 | 2,279 | 2,291 | 3,759 |
| Accrued Expenses | 6,594 | 6,110 | 8,285 | 6,747 | 4,526 |
| TOTAL | $9,471 | $13,736 | $10,982 | $9,447 | $8,685 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 248 | 388 | 269 | 376 | 482 |
| TOTAL | $248 | $388 | $269 | $376 | $482 |
| Total Liabilities | $9,719 | $14,124 | $11,251 | $9,823 | $9,167 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,015 | 25,978 | 25,910 | 25,868 | 25,753 |
| Common Shares | 26 | 26 | 26 | 26 | 26 |
| Retained earnings | -195,676 | -173,660 | -154,751 | -132,519 | -116,214 |
| TOTAL | $151,784 | $170,648 | $186,659 | $206,673 | $220,815 |
| Total Liabilities And Equity | $161,503 | $184,772 | $197,910 | $216,496 | $229,982 |